AzTrials
AzTrials

Humeral Diaphysis FractureNCT01116349

Conservative Treatment Versus the Surgical Treatment of Diaphyseal Fractures of Humerus

A study testing Plate and screws or nailing and Hanging Support System (HSS) brace in people with Humeral Diaphysis Fracture, run by Hopital de l'Enfant-Jesus at 2 sites in Canada.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The fracture of the humeral diaphysis is a condition that represents 2% of all fractures. The conservative treatment of diaphyseal fractures of the humerus has long been considered the only option and the surgical treatment was primarily reserved for displaced fractures with no contact of bone ends. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Humeral Diaphysis Fracture
What is being tested?
Plate and screws or nailing and Hanging Support System (HSS) brace
Could I receive a placebo?
No, everyone receives an active treatment
How many people
4 participants
Where
2 sitesCanada
Study dates
Jan 2010to Jul 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Male or female over 18 years
  • Fracture of the humeral diaphysis
  • Recent fracture (14 days or less)
  • Closed fracture
  • Signing of consent form

Who cannot join

  • Segmental fracture of the humerus
  • Fracture with proximal or distal intra articular extension
  • Open fracture
  • Polytrauma
  • Floating elbow or shoulder
  • Pathological fracture
Show all 13Show fewer
  • Simultaneous fracture of both humerus
  • Associated vascular disease
  • Severe neuromuscular disorders such as Parkinson, hemiparesis, myasthenia gravis, muscular dystrophy, etc. ...
  • medical contraindication to surgery
  • severe central neurological disease disabling patient to fill in questionnaires (senile dementia, Alzheimer's, etc ...
  • Male or female unable to consent
  • Any other condition which prevents the assessor from fully monitoring the patient during study

Trial locations and contacts

2 sites in 1 country.

Canada2 sites
  • CHA-Pavillon Enfant-Jésus

    Québec, Quebec, G1J 1Z4

  • Hôpital l'Enfant-Jésus

    Québec, Quebec, G1J 1Z4

Other trials in Canada

About this study

Official title: Diaphyseal Fractures of the Humerus: A Prospective Cohort Study Comparing the Conservative Treatment and the Surgical Treatment.

The fracture of the humeral diaphysis is a condition that represents 2% of all fractures. The conservative treatment of diaphyseal fractures of the humerus has long been considered the only option and the surgical treatment was primarily reserved for displaced fractures with no contact of bone ends. However, for a few years there has been an upsurge of indications for the surgical treatment of diaphyseal fractures.

The purpose of this study is to compare the functional outcomes and the quality of life of surgically treated patients versus those who undergo a conservative treatment.

Being tested
Plate and screws or nailing, Hanging Support System (HSS) brace
Keywords
humeral diaphysis fracture, plate and screws for humeral diaphysis fracture, nailing for humerus diaphysis fracture, Hanging Support System

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Plate and screws or nailingProcedure or surgery

    Patients included in the surgical group will be divided into two subgroups according to the method of fixation chosen: plate and screws or nailing. Surgeries take place under general anesthesia and a prophylaxis antibiotic is administrated. The installation and the approach will be chosen by the surgeon according to his preferences. A thoraco brachial brace is placed on the patient at the end of the intervention and it remains in place for a period of 5 to 10 days (patient comfort). A gradual mobilization of the elbow and shoulder will be initiated by the patient at home. The addition of physical therapy will be decided by the surgeon and noted down accordingly.

  • Hanging Support System (HSS) braceDevice

    Patients included in the conservative group will be taken to a plaster room where the HSS brace will be installed by a qualified technician. Advice will be provided for the care, personal hygiene and clothing. The brace will be kept for a period of 6 to 12 weeks depending on the degree of healing of fracture. The maintenance of the proximal part (Brace) may be recommended by the surgeon. The mobilization will begin with exercises at home and whether the patient does physical therapy or not is the surgeon's choice.

Study groups in NCT01116349
Study groupRoleWhat they receive
Surgical treatmentActive comparatorPatients included in the surgical group will have surgery to treat the fracture.
Receives: Procedure: Plate and screws or nailing
Conservative treatment groupActive comparatorPatients included in the conservative group will be taken to a plaster room where a Hanging Support System(HSS) brace will be installed by a qualified technician.
Receives: Device: Hanging Support System (HSS) brace

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Function and quality of life on DASH scale

    The function and quality of life are measured using the DASH scale six months after treatment.

    Measured: 6 months after treatment

Secondary outcomes (28)
  1. DASH score

    The function and quality of life are measured using the DASH scale 6 months after treatment.

    Measured: 6 months after treatment

  2. Return to professional activities

    It will be determined in days after surgery, to rates of 50% and 100% of the usual workload.

    Measured: 3 months after treatment

  3. SF-36 score

    This score will help validate the impact on quality of life of both types of treatment. It includes 36 items asking about the recent quality of life. This will also enable better understanding of the impact in real time on the functional level.

    Measured: 6 months after treatment

  4. DASH score

    The function and quality of life are measured using the DASH scale 12 months after treatment.

    Measured: 12 months after treatment

  5. SF-36 score

    This score will help validate the impact on quality of life of both types of treatment. It includes 36 items asking about the recent quality of life. This will also enable better understanding of the impact in real time on the functional level.

    Measured: 12 months after treatment

  6. Proportion of additional surgeries

    The evaluation of the rate of complications such as infection, implant removal, non-union, implant failure or malunion which necessitate additional surgery.

    Measured: 12 months after surgery

  7. Radiological loss of reduction

    The main observed displacements occur in varus and are measured on an AP view of the humerus. Initial displacements are tolerated up to 20 degrees in varus and in flexion.

    We measure the proportion of patients who experienced worsening of the deformity of more than 5 degrees on both levels.

    Measured: 2 weeks after treatment

  8. Radiological loss of reduction

    The main observed displacements occur in varus and are measured on an AP view of the humerus. Initial displacements are tolerated up to 20 degrees in varus and in flexion.

    We measure the proportion of patients who experienced worsening of the deformity of more than 5 degrees on both levels.

    Measured: 6 weeks after treatment

  9. Radiological loss of reduction

    The main observed displacements occur in varus and are measured on an AP view of the humerus. Initial displacements are tolerated up to 20 degrees in varus and in flexion.

    We measure the proportion of patients who experienced worsening of the deformity of more than 5 degrees on both levels.

    Measured: 12 weeks after treatment

  10. Radiological loss of reduction

    The main observed displacements occur in varus and are measured on an AP view of the humerus. Initial displacements are tolerated up to 20 degrees in varus and in flexion.

    We measure the proportion of patients who experienced worsening of the deformity of more than 5 degrees on both levels.

    Measured: 6 months after treatment

  11. Union rate

    The union is defined by the presence of a strong radiological callus associated with lack of pain at the fracture site. The humerus unifies in an average of three months. It is considered non-union if it is not unified after six months, and it is classified as delayed union between 3 and 6 months.

    The rates will be presented by the number of patients with non-union in each group.

    Measured: 12 weeks after treatment

  12. Union rate

    The union is defined by the presence of a strong radiological callus associated with lack of pain at the fracture site. The humerus unifies in an average of three months. It is considered non-union if it is not unified after six months, and it is classified as delayed union between 3 and 6 months.

    The rates will be presented by the number of patients with non-union in each group.

    Measured: 6 months after treatment

  13. Rates of complication

    The main complications recognized in the treatment of humerus fractures are: infection, nerve damage, malunion and non-unions. Each complication will be recorded and reported.

    Measured: within the first year following treatment

  14. Pain on visual analogue pain scale (VAS)

    The measure will be carried out using a suitable rule designed for this type of measurement, counting only full of numbers 1 to 10.

    Measured: 2 weeks after treatment

  15. Pain on VAS

    The measure will be carried out using a suitable rule designed for this type of measurement, counting only full of numbers 1 to 10.

    Measured: 6 weeks after treatment

  16. Pain on VAS

    The measure will be carried out using a suitable rule designed for this type of measurement, counting only full of numbers 1 to 10.

    Measured: 12 weeks after treatment

  17. Pain on VAS

    The measure will be carried out using a suitable rule designed for this type of measurement, counting only full of numbers 1 to 10.

    Measured: 6 months after treatment

  18. Pain on VAS

    The measure will be carried out using a suitable rule designed for this type of measurement, counting only full of numbers 1 to 10.

    Measured: 12 months after treatment

  19. Measurement of range of motion of the shoulder

    Using a goniometer, we will measure the bending (normal value 180 °), abduction (180°), external rotation in the scapular plane (90 °) and internal rotation in the plane scapula (60°).

    Measured: 2 weeks after treatment

  20. Measurement of range of motion of the shoulder

    Using a goniometer, we will measure the bending (normal value 180 °), abduction (180°), external rotation in the scapular plane (90 °) and internal rotation in the plane scapula (60°).

    Measured: 6 weeks after treatment

  21. Measurement of range of motion of the shoulder

    Using a goniometer, we will measure the bending (normal value 180 °), abduction (180°), external rotation in the scapular plane (90 °) and internal rotation in the plane scapula (60°).

    Measured: 12 weeks after treatment

  22. Measurement of range of motion of the shoulder

    Using a goniometer, we will measure the bending (normal value 180 °), abduction (180°), external rotation in the scapular plane (90 °) and internal rotation in the plane scapula (60°).

    Measured: 6 months after treatment

  23. Measurement of range of motion of the shoulder

    Using a goniometer, we will measure the bending (normal value 180 °), abduction (180°), external rotation in the scapular plane (90 °) and internal rotation in the plane scapula (60°).

    Measured: 12 months after treatment

  24. Measurement of range of motion of the elbow

    Using a goniometer, we will measure the bending (normal value 140 °), extension (normal value 0 °), pronation (normal value 80 °) and supination (normal value 80 °).

    Measured: 2 weeks after treatment

  25. Measurement of range of motion of the elbow

    Using a goniometer, we will measure the bending (normal value 140 °), extension (normal value 0 °), pronation (normal value 80 °) and supination (normal value 80 °).

    Measured: 6 weeks after treatment

  26. Measurement of range of motion of the elbow

    Using a goniometer, we will measure the bending (normal value 140 °), extension (normal value 0 °), pronation (normal value 80 °) and supination (normal value 80 °).

    Measured: 12 weeks after treatment

  27. Measurement of range of motion of the elbow

    Using a goniometer, we will measure the bending (normal value 140 °), extension (normal value 0 °), pronation (normal value 80 °) and supination (normal value 80 °).

    Measured: 6 months after treatment

  28. Measurement of range of motion of the elbow

    Using a goniometer, we will measure the bending (normal value 140 °), extension (normal value 0 °), pronation (normal value 80 °) and supination (normal value 80 °).

    Measured: 12 months after treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 May 2010 (estimated)
  2. Study startJan 2010
  3. Primary completionDec 2012 (estimated)
  4. Study completionJul 2014 (estimated)

Why it stopped: Difficulties to recruit participants A similar Canadian multicentric study started at about the same.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
4 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01116349
Sponsor's protocol ID
PEJ-530
Status last verified
Dec 2012
First submitted
3 May 2010
Last updated
20 Dec 2012
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Plate and screws or nailing and Hanging Support System (HSS) brace in people with Humeral Diaphysis Fracture, run by Hopital de l'Enfant-Jesus at 2 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 20 Dec 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Difficulties to recruit participants A similar Canadian multicentric study started at about the same.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Function and quality of life on DASH scale (time frame: 6 months after treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Dec 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in